Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.

Autor: Tate M; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Department of Diabetes, Monash University, Melbourne, VIC, Australia., Higgins GC; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle AlbertiMemorial Centre for Diabetic Complications, Diabetic Complications Division,, Baker Heart and Diabetes Institute, Melbourne, Australia., De Blasio MJ; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Lindblom R; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle AlbertiMemorial Centre for Diabetic Complications, Diabetic Complications Division,, Baker Heart and Diabetes Institute, Melbourne, Australia., Prakoso D; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Deo M; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Kiriazis H; Experimental Cardiology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Park M; Department of Medicine, University of Cambridge, Cambridge, Biomedical Campus, Cambridge, UK., Baeza-Garza CD; Department of Medicine, University of Cambridge, Cambridge, Biomedical Campus, Cambridge, UK., Caldwell ST; WestCHEM School of Chemistry, University of Glasgow, G12 18QQ, Glasgow, UK., Hartley RC; WestCHEM School of Chemistry, University of Glasgow, G12 18QQ, Glasgow, UK., Krieg T; Department of Medicine, University of Cambridge, Cambridge, Biomedical Campus, Cambridge, UK., Murphy MP; Department of Medicine, University of Cambridge, Cambridge, Biomedical Campus, Cambridge, UK.; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0XY, UK., Coughlan MT; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle AlbertiMemorial Centre for Diabetic Complications, Diabetic Complications Division,, Baker Heart and Diabetes Institute, Melbourne, Australia., Ritchie RH; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. Rebecca.Ritchie@baker.edu.au.; Department of Diabetes, Monash University, Melbourne, VIC, Australia. Rebecca.Ritchie@baker.edu.au.
Jazyk: angličtina
Zdroj: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2020 Apr; Vol. 34 (2), pp. 223.
DOI: 10.1007/s10557-019-06929-2
Abstrakt: The article "The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart".
Databáze: MEDLINE
Externí odkaz: